Bayer: Guidance is either in line or at the low-end of expectations

BUY, Fair Value EUR75 (+2%)

News published on February Thursday 28, 2013
Share on
Bayer has just published its Q4 numbers with sales of EUR9,862m, slightly above consensus. However Core EPS was in line to marginally below expectations (EUR1.00 vs EUR1.05) specifically due to a margin in CropScience that fell short of expectations. Looking forward into 2013 and 2015, the company is guiding the market towards targets that are already well captured by the street or are at the bottom part of the range.

Full report available to subscribers
Please contact 

The Essentials

Everything you need to know about investment banking dedicated to growth
Recent Transactions Highlights
From M&A, to IPOs see what’s been happening at Bryan, Garnier & Co this year
Join our Team
Bryan, Garnier & Co is always looking for talent in all our divisions, at all levels
Explore our opportunities